380 related articles for article (PubMed ID: 26733172)
1. Number of negative lymph nodes as a prognostic factor for ypN0-N1 breast cancer patients undergoing neoadjuvant chemotherapy.
Xin F; Yu Y; Yang ZJ; Hou LK; Mao JF; Xia L; Wang X; Cao XC
Tumour Biol; 2016 Jun; 37(6):8445-54. PubMed ID: 26733172
[TBL] [Abstract][Full Text] [Related]
2. [The role of postmastectomy radiotherapy in clinical T1-3N1M0 breast cancer patients with pathological negative lymph nodes after neoadjuvant chemotherapy and mastectomy].
Rong QL; Wang SL; Tang Y; Jin J; Song YW; Wang WH; Liu YP; Fang H; Ren H; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):445-452. PubMed ID: 28635235
[No Abstract] [Full Text] [Related]
3. Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy.
Wu SG; Sun JY; Zhou J; Li FY; Zhou H; Lin Q; Lin HX; Bao Y; He ZY
Radiat Oncol; 2014 Dec; 9():284. PubMed ID: 25511525
[TBL] [Abstract][Full Text] [Related]
4. Indications for Postmastectomy Radiation After Neoadjuvant Chemotherapy in ypN0 and ypN1-3 Axillary Node-Positive Women.
Fowble B; Jairam AK; Wang F; Peled A; Alvarado M; Ewing C; Esserman L; Park C; Lazar A
Clin Breast Cancer; 2018 Feb; 18(1):e107-e113. PubMed ID: 28830795
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases.
van Nijnatten TJ; Simons JM; Moossdorff M; de Munck L; Lobbes MB; van der Pol CC; Koppert LB; Luiten EJ; Smidt ML
Breast Cancer Res Treat; 2017 May; 163(1):159-166. PubMed ID: 28213782
[TBL] [Abstract][Full Text] [Related]
6. Postmastectomy Radiation Therapy Based on Pathologic Nodal Status in Clinical Node-Positive Stage II to III Breast Cancer Treated with Neoadjuvant Chemotherapy.
Huang Z; Zhu L; Huang XB; Tang Y; Rong QL; Shi M; Wang WH; Tie J; Shen LF; Chen JY; Zhang J; Wu HF; Cheng J; Liu M; Tan YT; Ma CY; Wang SL; Li YX
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):1030-1039. PubMed ID: 32585337
[TBL] [Abstract][Full Text] [Related]
7. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.
Rusthoven CG; Rabinovitch RA; Jones BL; Koshy M; Amini A; Yeh N; Jackson MW; Fisher CM
Ann Oncol; 2016 May; 27(5):818-27. PubMed ID: 26861597
[TBL] [Abstract][Full Text] [Related]
8. The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB.
Liu J; Mao K; Jiang S; Jiang W; Chen K; Kim BY; Liu Q; Jacobs LK
Oncotarget; 2016 Apr; 7(17):24848-59. PubMed ID: 26709538
[TBL] [Abstract][Full Text] [Related]
9. The role of postmastectomy radiation therapy after neoadjuvant chemotherapy in clinical stage II-III breast cancer patients with pN0: a multicenter, retrospective study (KROG 12-05).
Shim SJ; Park W; Huh SJ; Choi DH; Shin KH; Lee NK; Suh CO; Keum KC; Kim YB; Ahn SD; Kim SS; Ha SW; Chie EK; Kim K; Shin HS; Kim JH; Lee HS
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):65-72. PubMed ID: 24161425
[TBL] [Abstract][Full Text] [Related]
10. Using the Lymph Node Ratio to Evaluate the Prognosis of Stage II/III Breast Cancer Patients Who Received Neoadjuvant Chemotherapy and Mastectomy.
Wu SG; Li Q; Zhou J; Sun JY; Li FY; Lin Q; Lin HX; Gaun XX; He ZY
Cancer Res Treat; 2015 Oct; 47(4):757-64. PubMed ID: 25672578
[TBL] [Abstract][Full Text] [Related]
11. Impact of Postmastectomy Radiation Therapy on Breast Cancer Patients According to Pathologic Nodal Status after Modern Neoadjuvant Chemotherapy.
Kim D; Kim JH; Kim IA; Chang JH; Shin KH
Cancer Res Treat; 2023 Apr; 55(2):592-602. PubMed ID: 36228653
[TBL] [Abstract][Full Text] [Related]
12. Number of negative lymph nodes is associated with disease-free survival in patients with breast cancer.
Wu SG; Sun JY; Zhou J; Li FY; Lin Q; Lin HX; Guan XX; He ZY
BMC Cancer; 2015 Feb; 15():43. PubMed ID: 25880737
[TBL] [Abstract][Full Text] [Related]
13. Number of negative lymph nodes can predict survival after postmastectomy radiotherapy according to different breast cancer subtypes.
Wu SG; Peng F; Zhou J; Sun JY; Li FY; Lin Q; Lin HX; Bao Y; He ZY
J Cancer; 2015; 6(3):261-9. PubMed ID: 25663944
[TBL] [Abstract][Full Text] [Related]
14. Postmastectomy Radiation in Breast Cancer Patients With Pathologically Positive Lymph Nodes After Neoadjuvant Chemotherapy: Usage Rates and Survival Trends.
Ohri N; Moshier E; Ho A; Green S; Rhome R; Mazumdar M; Powell S; Tsai CJ
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):549-559. PubMed ID: 29280449
[TBL] [Abstract][Full Text] [Related]
15. Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy is Prognostic in Hormone Receptor-Positive and Triple-Negative Breast Cancer.
Tsai J; Bertoni D; Hernandez-Boussard T; Telli ML; Wapnir IL
Ann Surg Oncol; 2016 Oct; 23(10):3310-6. PubMed ID: 27401442
[TBL] [Abstract][Full Text] [Related]
16. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
White R; Dinneen T; Makris A
Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy for stage II and stage III breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy.
Le Scodan R; Selz J; Stevens D; Bollet MA; de la Lande B; Daveau C; Lerebours F; Labib A; Bruant S
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e1-7. PubMed ID: 21377284
[TBL] [Abstract][Full Text] [Related]
18. Nodal Response to Neoadjuvant Chemotherapy Predicts Receipt of Radiation Therapy After Breast Cancer Diagnosis.
Fayanju OM; Ren Y; Suneja G; Thomas SM; Greenup RA; Plichta JK; Rosenberger LH; Force J; Hyslop T; Hwang ES
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):377-389. PubMed ID: 31678225
[TBL] [Abstract][Full Text] [Related]
19. Post-mastectomy radiation therapy and overall survival after neoadjuvant chemotherapy.
Kantor O; Pesce C; Singh P; Miller M; Tseng J; Wang CH; Winchester DJ; Yao K
J Surg Oncol; 2017 May; 115(6):668-676. PubMed ID: 28083910
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
